3 ms·
Data needs to be built, but who can say no to a supplement that's relatively cheaply available, in ample supply and doesn't hurt to take reasonable doses over a
by 2ion 6y ago
Data needs to be built, but who can say no to a supplement that's relatively cheaply available, in ample supply and doesn't hurt to take reasonable doses over a few weeks?
- ketamine__ 6y agoClinical trial success is around 14%. Most things fail. Remember Curcumin? https://blogs.sciencemag.org/pipeline/archives/2017/01/12/curcumin-will-waste-your-time https://blogs.sciencemag.org/pipeline/archives/2017/01/12/cu... > Taking the properties and activities all together, though, these efforts would seem to be largely – and almost certainly completely – wastes of time and money. What’s worse, it appears that from 2001 on there are at least 135 registered clinical trials using the stuff. The review goes into four examples for which details are available, all of them complete wipeouts, and those would seem to serve as good proxies for the rest given that no curcumin trial has ever reported any convincing positive results.